PSIGMA
Investment Week | 03 Feb 2012
Punter Southall has taken full control of PSigma Asset Management, taking over a 50% stake from the boutique's founders.
Former BlackRock analyst Burstow to run new Global Mining offering for Barings, with mandate to invest in mining equities across cap scale.
Investment Week | 16 Jan 2012
It is the time of year when we all start gazing in to the New Year with hope. I don’t know about anyone else, but I cannot wait for this year to end.
Investment Week | 12 Dec 2011
OTHER PSIGMA ARTICLES
PSigma’s Bill Mott has shaped his portfolio for a multi-year period of anaemic growth, which will see markets seesaw as investors switch between risk on and risk off trades.
Investment Week | 01 Dec 2011
BP’s robust results lifted shares in the oil major last week but provoked mixed reactions as managers debate whether now is the time to buy back in
Investment Week | 31 Oct 2011
This week saw a round of updates from some of the UK's largest dividend payers, including BP, Shell, Glaxo and British American Tobacco. But is it time for investors to be selling the big names?
Investment Week | 28 Oct 2011
Top performing UK fund managers including Ed Legget at Standard Life Investments and PSigma’s Bill Mott have been buying up mining stocks in recent weeks following a major market sell-off.
Investment Week | 17 Oct 2011
PSigma’s Tom Becket believes the FTSE 100 could rise 10% by the end of year as European policymakers look set to recapitalise the Continent's highly indebted banks, boosting investor sentiment.
Investment Week | 28 Sep 2011
Emerging economies would face a systemic crisis if foreign investors, who own one-third of EM local currency debt markets, begin to pull out their cash, fund managers have warned.
Investment Week | 26 Sep 2011
Pharma stocks could be “dramatically re-rated” in the next three to four years, said PSigma’s Bill Mott, as analysts realise it is one of the few sectors that can deliver shareholder returns in the face of economic uncertainty.
Investment Week | 25 Jul 2011
Income stars such as Neil Woodford and Bill Mott are set for boosts to their portfolios as AstraZeneca jumped over 3% this morning following the approval of a drug the pharma giant pinned $2bn of future sales.
Investment Week | 21 Jul 2011
PSigma's Tom Becket says confidence is vital to ensuring a tentative recovery.
Investment Week | 27 Jun 2011
PSigma’s James Abate is set to use a GDP-focused benchmark in his new Global Equity fund, which launches on 17 June.
Investment Week | 07 Jun 2011
PSigma’s Bill Mott has tipped UK pharmaceutical giants AstraZeneca and GlaxoSmithKline to double investors’ cash over the next three to five years.
Investment Week | 23 May 2011
PSigma has changed the name of its bottom quartile £10m American Growth fund to the PSigma American fund.
Investment Week | 12 May 2011
HAVE YOUR SAY
This week: Are hopes of a US recovery overblown?
JOB OF THE WEEK
EVENTS
08 Feb 2012 - 08 Feb 2012
Radisson Blu, 80 High Street, The Royal Mile Edinburgh
09 Feb 2012 - 09 Feb 2012
London Hilton on Park Lane, 22 Park Lane, London, W1K 1BE